How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
University of Western Ontario, Division of Cardiology, London, Ontario, Canada.
Manoj N
MN
Obeyesekere
George J
GJ
Klein
Simon
S
Modi
Peter
P
Leong-Sit
Lorne J
LJ
Gula
Raymond
R
Yee
Allan C
AC
Skanes
Andrew D
AD
Krahn
D000200:Action Potentials; D000322:Adrenergic Agonists; D000889:Anti-Arrhythmia Agents; D053840:Brugada Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D004562:Electrocardiography; D005080:Exercise Test; D006329:Heart Conduction System / Q000503:physiopathology*; D006339:Heart Rate; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D011237:Predictive Value of Tests; D020127:Recovery of Function; D017180:Tachycardia, Ventricular / Q000175:diagnosis* / Q000503:physiopathology; D013997:Time Factors; D000098850:Polymorphic Catecholaminergic Ventricular Tachycardia
D000322:Adrenergic Agonists; D000889:Anti-Arrhythmia Agents